Muscleblind-like protein 1, MBNL1, mouse monoclonal, Cat# MCA-1H1

Muscleblind-like protein 1, MBNL1, mouse monoclonal, Cat# MCA-1H1

HeLa cells were stained with monoclonal antibody MCA-1H1 at a dilution of 1:1,000. Muscleblind-like protein 1 is present in the nucleii of HeLa cells (red). Co-staining is with our rabbit polyclonal antibody against vimentin RPCA-Vim, in green reveals cytoplasmic intermediate filaments.  Blue is a DNA stain which largely colocalizes with the MBNL1 protein in the nucleus.

Western blot analysis of MCA-1H1. Blot of HL60 cell lysate was probed with MCA-1H1 at a dilution 1:1,000. The MCA-1H1 monoclonal binds Muscleblind-like protein 1 at ~40kDa, as expected.

Product name Anti-Muscleblind like protein 1
Description Mouse Monoclonal to Muscleblind like protein 1.
Reference Code MCA-1H1
RRID# AB_2572351
Molecular weight 39kDa
Immunogen Full-length recombinant human Muscleblind-like 1 protein
Isotype IgG1
Concentration Antibody is supplied as an aliquot of 1 mg/mL of affinity purified antibody.
Species Reactivity Human, horse, cow, pig, chicken, rat, mouse
Applications Western blot, ICC/IF, IHC
Suggestions for use Western blots: 1:1,000-1:2,000.
ICC/IF or IHC: 1:1,000.

Muscleblind was originally isolated following studies of Drosophila, since inactivation of the muscleblind (mbl) gene in this species resulted in defects the development of both muscles and the visual system (1). The Drosophila Muscleblind protein contains 4 so called Zn-CCCH Motifs (a.k.a. Cys3His or C3H motifs), members of the Zinc finger family of nucleic acid binding motifs. The Zn-CCCH motifs are about 26 amino-acids long, and each coordinate one Zinc ion and may bind RNA. Human homologues of the single Drosophila muscleblind gene were discovered from cDNA and genomic sequencing, but were also discovered as a result of experiments aimed at finding proteins which bind to polynucleotide repeated sequences. Several important human diseases are associated with expansion of polynucleotide sequences, in most cases trinucleotide repeats. Myotonic dystrophy (DM1) is one of these diseases, and is associated with increases in the number of CTG trinucleotide repeats in the 3′ UTR of the gene encoding myotonin (a.k.a. DM Kinase, DMK or myotonin protein kinase), a ser/thr kinase expressed specifically in muscle. Normal humans have 5-37 tandem CTG repeats in this gene while those with myotonic dystrophy have from 50 to as many as 1,000 CTG repeats, with individuals with the most serious forms of the disease generally having the most repeats. Since the increased repeats were found in the 3′ untranslated region (UTR) of the myotonin gene and so do not encode protein, it was puzzling as to how the increased number repeats caused the disease, especially since knock out of the myotonin gene has a relatively mild phenotype (2, 3). One theory is that the repeated sequences sequester important RNA binding and processing proteins and hence reduced the efficiency of RNA processing which would have a generally deleterious effect. To test this theory Miller et al. (4) looked for proteins that would bind specifically to the product of genomic CTG repeats in the 3′ UTR, double stranded CUG RNA repeats. They found several which they named EXP proteins, for triplet repeat expansion dsRNA-binding proteins. These proteins were then identified as the mammalian homologues of the Drosophila Muscleblind protein. Mammalian genomes contain three muscleblind-like proteins, generally referred to as MBNL1, MBNL2 and MBNL3, and all three were found to associate with long double stranded CUG RNA repeats. In situ hybridization studies in mouse show that all three genes are widely expressed especially in development and show significant overlap with myotonin expression (5). Recent studies show that transgenic knock out of MBNL1 in mice results in a phenotype similar to that of myotonic dystrophy, and also reduced efficiency of mRNA processing similar to those seen in this disease, both observations supporting the RNA sequestration theory (6). Although the exact function of Muscleblind proteins is not known, this and other evidence suggests that they have a role in RNA splice site selection (6).

1. Begemann G, Paricio N, Artero R, Kiss I, Perez-Alonso M. and Mlodzik M. Muscleblind, a gene required for photoreceptor differentiation in Drosophila, encodes novel nuclear Cys3His-type Zinc-finger-containing proteins. Development 124:4321-4331 (1997).

2. Jansen G et al. Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nat Genet. 13:316-324 (1996)

3. Reddy S et al. Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nat Genet. 13:325-335 (1996)

4. Miller JW, Urbinati CR, Teng-Umnuay P, Stenberg MG, Byrne BJ, Thornton CA and Swanson MS. Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy. EMBO J. 19:4439-4448 (2000).

5. Kanadia RN, Urbinati CR, Crusselle VJ, Luo D, Lee YJ, Harrison JK, Oh SP and Swanson MS. Developmental expression of mouse muscleblind genes Mbnl1, Mbnl2 and Mbnl3. Gene Expr. Patterns 3:459-462 (2003).

6. Kanadia RN, Johnstone KA, Mankodi A, Lungu C, Thornton CA, Esson D, Timmers AM, Hauswirth WW and Swanson MS. A muscleblind knockout model for myotonic dystrophy. Science 302:1978-1980 (2003).

Download Adobe Acrobat format product data sheet: .